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Syncope is a common clinical problem, but nevertheless is but one element of the broader
issue of ‘transient loss of consciousness’ (TLOC). The ﬁrst step is to ascertain whether the
patient actually suﬀered a syncopal episode, and thereafter the goal must be to determine the
basis of symptoms with suﬃcient conﬁdence to assess prognosis and initiate an eﬀective
treatment strategy. The initial evaluation of these patients, which usually takes place in an
emergency department (ED) or acute care facility, is challenging since patients are usually
asymptomatic when they come for medical attention, may have little or no recall of the event,
and witnesses, if any, often cannot provide reliable information. Given these circumstances, it
is understandable that frontline physicians often tend to take a seemingly ‘safe’ approach, and
admit both high-risk and intermediate-risk syncope patients to hospital. This strategy has
many implications, including life-style and economic concerns for the patient, and health care
management issues for physicians, hospital administrators and the overall health care system.
The European Society of Cardiology (ESC) guidelines and several clinical studies provide
helpful advice regarding ‘‘risk stratiﬁcation’’ to help guide physicians in selecting patients for
either early hospital admission or later oupatient subspeciality evaluation. The utility of
syncope management units in the ED, and a guideline-based approach to the syncope patient,
has tended to both diminish the number of undiagnosed cases and reduce the hospital
admission rate. In this review, we have attempted to both highlight a cost-eﬀective diagnostic
pathway beginning with the initial evaluation of the patient with suspected syncope, and to
provide criteria which may help frontline physicians better base their decisions regarding need
for in-hospital versus outpatient clinic evaluation of syncope patients.
(J Arrhythmia 2008; 24: 111–121)
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Introduction
Syncope is a syndrome characterized by a rela-
tively sudden, temporary and self-terminating loss of
consciousness; the causes may vary widely from
patient to patient, but they have a common under-
lying pathophysiology; speciﬁcally, the transient loss
of consciousness in syncope patients is the result of a
temporary inadequacy of cerebral nutrient ﬂow, most
often triggered by a fall in systemic arterial pressure
below the minimum needed to sustain cerebral blood
ﬂow.
Despite the fact that syncope is a relatively
common clinical problem,1–3) it is only one of many
possible explanations for episodic transient loss of
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consciousness (TLOC) (Table 1). The diﬀerential
diagnosis of TLOC is extensive. Consequently, the
diagnostic evaluation should start not with the focus
solely on ‘syncope’, but more broadly with consid-
eration of a range of possible causes for real (e.g.
seizures and concussion) or seemingly real (e.g.
narcolepsy and certain psychogenic disturbances)
TLOC (Table 1).1) Thus, epilepsy, concussions, met-
abolic disturbances and intoxications, and ‘syncope
mimics’ need to be considered. In each of these
cases, the pathophysiology of disturbance of con-
sciousness diﬀers from that of syncope, and there-
fore treatment would also be entirely diﬀerent. For
instance, seizures are a primary electrical disturb-
ance of brain function, concussion is a disturbance of
consciousness triggered by trauma, metabolic dis-
turbances and/or intoxications may cause TLOC
as the result of adverse toxic eﬀects on cerebral
function, while the basis for the so-called ‘syncope
mimics’ varies and is poorly understood.
Among those patients in whom TLOC is deemed
to be due to true syncope, the next step is thorough
evaluation of the underlying cause. This is an
important matter, since syncope, while perhaps
relatively benign from a mortality perspective in
the vast majority of cases, is nevertheless only
infrequently an isolated event; syncope tends to
recur, and physical injury resulting from falls or
accidents, diminished quality-of-life, and possible
restriction from employment or avocation are real
concerns. Determining that certain individuals are
at ‘low mortality risk’ is insuﬃcient. The goal in
every case should be to determine the cause of
syncope with suﬃcient conﬁdence to provide
patients and family members with a reliable assess-
ment of prognosis, recurrence risk, and treatment
options.
In this review we summarize a strategy for
undertaking the syncope evaluation. The objective
is to determine, with as much certainty as possible,
the basis for the patient’s symptoms; only then is it
possible to evaluate prognosis and deﬁne an eﬀective
treatment plan.
Initial evaluation
The initial medical evaluation of patients present-
ing with suspected syncope usually occurs in the
Emergency Department (ED) or acute care clinic.
After determining as best as possible that the patient
has experienced true syncope, the initial evaluation
should then focus on the following key points
. A detailed description of symptomatic events
. Ascertaining whether clinically important
structural heart disease is present
. Clinical features of the history that suggest a
diagnosis.
As a rule, the initial evaluation begins with a
comprehensive medical history and physical exami-
nation, an electrocardiogram (ECG) and often an
echocardiogram. In experienced hands, the cause of
syncope can be established by these steps alone in
approximately 60 percent of patients.4,5)
Even after it is concluded that ‘syncope’ was the
most likely cause of TLOC, the subsequent clinical
assessment remains challenging for a number of
reasons. First, the aﬀected individual is usually
asymptomatic on arrival for medical attention.
Consequently, it is rare to ﬁnd any helpful physical
ﬁndings or ECG observations. Second, the victim
(especially if in an older age group) may not be able
to provide a detailed history of the circumstances,
and in other cases the reported history may not be
reliable. Third, the event(s) may not have been
witnessed, or even if witnessed, the observer is often
unable to recollect details. The physician must spend
considerable time elicting the story as best as
possible. Finally, syncope has many possible causes
(Table 2), and each needs to be carefully considered.
The medical history is the physician’s most
valuable tool in the initial syncope assessment. Not
infrequently the history alone is diagnostic of the
cause of syncope and no further testing is needed.
The most common example is when the history is
indicative of a ‘classic’ vasovagal faint or one of
the so-called ‘situational’ neurally-mediated reﬂex
Table 1 Causes of real or apparent transient loss of consciousness (T-LOC)1Þ
Syncope Non-syncope
 Neurally mediated (reﬂex)  Disorders resembling syncope without
 Orthostatic hypotension any impairment of consciousness, e.g
 Cardiac arrhythmias as primary cause falls, psychogenic pseudo-syncope, etc
 Structural cardiac or cardiopulmonary  Disorders with partial or complete loss of
disease consciousness, e.g seizure disorders, etc.
 Cerebrovascular
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faints. In such cases, an experienced physician can
feel comfortable that the basis for symptoms has
been determined, and can proceed with appropriate
treatment steps. On the other hand, if the careful
history is suggestive but inconclusive, the physician
has still made considerable progress; subsequent
steps in the evaluation can be focused, eﬃcient, and
cost-eﬀective (Figure). A ‘shotgun’ approach to
diagnosis is to be avoided.
Among the most important factors to identify in
the patient with suspected syncope is whether he/she
has a history of or physical ﬁndings suggestive of
underlying structural heart disease. In this regard, the
inclusion of an echocardiogram as part of the initial
evaluation of suspected syncope patients can be a
valuable aid for the clinician. The presence of heart
disease is an independent predictor of a ‘cardiac
cause’ for syncope (i.e., a primary arrhythmic
cause or a cause based on a structural cardiac
abnormality leading to a transient hemodynamic
disturbance), with a sensitivity of 95% and a
speciﬁcity of 45%; by contrast, the absence of heart
disease excludes a cardiac cause of syncope in 97%
of the patients.6)
Syncope in conjunction with exertion raises
special concerns. In particular, if the faint occurs in
‘full ﬂight’, one must consider the possibility of
structural and/or dynamic heart lesions producing
a relatively ‘ﬁxed’ cardiac output in the setting
of vascular dilatation (e.g., severe aortic or mitral
valvular stenosis, hypertrophic cardiomyopathy).
However, syncope during or early following exercise
(even moderate exertion such as climbing stairs)
can also occur in patients with severe autonomic
dysfunction (e.g., pure autonomic failure) in whom
vascular control is unable to maintain adequate
cerebral perfusion pressure. In addition, on rare
occasions syncope accompanying exertion may
occur as a consequence of a neurally-mediated reﬂex
faint (i.e., post-exertional variant of vasovagal faint);
however, in these latter cases the faint typically
occurs shortly after completion of, not during, the
exercise.
A comprehensive discussion of medical history
taking in patients with suspected syncope lies
beyond the scope of this review. However, we have
included in the Appendix a brief summary of certain
key features to be considered in this process. In brief,
Table 2 Main causes of syncope1Þ
Neurally-mediated (reﬂex)
 Vasovagal
 Carotid sinus syncope
 Situational syncope




 Drug (and alcohol)-induced orthostatic syncope
 Volume depletion
Cardiac arrhythmias as a primary cause
 Sinus node dysfunction
 Atrioventricular conduction system disease
 Paroxysmal supraventricular and ventricular arrhythmias
 Inherited syndromes (e.g long QT syndrome, Brugada syndrome)
 Implanted device malfunction
 Drug-induced pro-arrhythmias
Structural cardiac or cardiopulmonary disease
 Cardiac valvular disease
 Acute myocardial infarction or ischemia
 Obstructive cardiomyopathy
 Atrial myxoma
 Acute aort dissection
 Pulmonary embolus/pulmonary hypertension
Cerebrovascular
 Vascular steal syndromes
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it is essential that as many symptom events as
possible be reviewed in detail, the preceding circum-
stances, premonitory symptoms (Table 3), and sub-
sequent outcome should be documented, along with
careful note being made of co-morbidities (for
example diabetic neuropathy, autonomic dysfunc-
tion). If a pattern emerges regarding symptom
events, the diagnosis may become evident without
need for further tests or with the aid of only a few
selected conﬁrmatory tests. A pre-prepared patient
questionnaire may prove helpful to save time and yet
acquire the needed detail.
As alluded to earlier, based on a careful initial
evaluation the physician may determine that a
‘Certain’ diagnosis has been established and treat-
ment can be contemplated. However, in many
instances the initial assessment may yield only a
‘Suspected’ cause necessitating selected further test-
ing, or might be entirely unrevealing. In the latter
case the diagnosis remains unclear or ‘Unknown’.
For each of these circumstances, the diagnostic ﬂow
pathway illustrated in Figure (modiﬁed after that
devised by the European Society of Cardiology
Syncope Guidelines Task Force [ESC guideline])
may prove helpful. Ultimately, the goal is to
establish, in an eﬃcient and cost-eﬀective manner,
the cause(s) of syncope with suﬃcient conﬁdence to
provide patients and families a reliable recommen-
dation regarding prognosis and treatment options.
Risk stratiﬁcation in the emergency depart-
ment based on initial evaluation
Wherever the initial syncope evaluation leads,
Diagnosis unclear 
'Risk stratification'
  (outpatient vs in-hospital evaluation) 
 Suspected diagnosis 
· History  
· Physical examination 
· Supine and upright BP
· Standard ECG  
· Echocardiogram
No suspected diagnosis 
Structural heart disease 
or abnormal ECG 






· Stress test 
  
· EP study 
PositiveTreatment based on diagnosis 











'Risk stratification' for treatment 
Single or 
rare episodes 
Directed therapy  
Possibly
education/reassurance  
















Figure Initial evaluation and further management strategy of syncope based on European Society of Cardiology Task Force
Guidelines.1)
ECG, electrocardiogram; BP; blood pressure; AECG, ambulatory electrocardiogram; ILR, implantable loop recorder; EP, electro-
physiologic.
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physicians almost always face the question ‘‘Does
this individual need in-hospital care for further
evaluation and/or initiation of treatment?’’. The
outcome of this decision has many implications,
including life-style and economic concerns for the
patient, as well as health care management issues
(e.g. bed availability, hospital costs, and laboratory
utilization) for the broader health care system.
In general, the driving force determining whether
the patient with presumed syncope should be
hospitalized is most often concern regarding the
individual’s immediate mortality risk. Secondary
issues of importance include potential for physical
injury (e.g., falls risk), and to a lesser extent the issue
of whether certain treatments inherently require
hospital monitoring for safe initiation. In any case,
the current practice pattern for ED physcians and
general practitioners is to take a presumably ‘safe’
approach and admit a large proportion of syncope
patients to hospital. This strategy is mostly based
on the presumption that syncope is commonly a
harbinger of sudden death among patients. However,
most studies indicate that syncope, by itself, is not an
independent predictor of mortality. The real risk, in
the vast majority of cases (exclusions may be the
‘channelopathies’), is the risk associated with any
evident coexisting cardiovascular disease.7)
In terms of the apparent preference for frontline
physicians to admit syncope patients to hospital,
Bartoletti et al.8) evaluated the frequency with which
ED physicians who were specially trained with
respect to ESC Guidelines (particularly with regard
to hospital admission recommendations), elected in-
hospital or outpatient evaluation for patients pre-
senting with syncope. During the approximate 2-year
enrollment, 1,124 patients were deemed to have true
syncope and 440 of these (39%) had at least one
marker supporting admission for evaluation; 393 of
these 440 patients (89%) were admitted. In contrast,
684 patients met no evident admission criterion; 511
of 684 patients (75%) were appropriately discharged
from the ED, but 25% were admitted. The high 25%
admission rate in the low-risk patients despite being
backed-up by guideline statement showed that
among ED physicians there remain unresolved
problems that need to be addressed in order to
decrease potentially unnecessary hospital admis-
sions.
In instances when the etiology of syncope is
considered ‘certain’ after the initial clinical evalua-
Table 3 Clinical features suggestive of speciﬁc causes of real or apparent loss of consciousness1Þ
Neurally mediated syncope
 Absence of cardiac disease
 Long history of syncope
 After sudden unexpected sight, sound, smell or pain
 Prolonged standing or crowded, hot places
 Nausea, vomitting associated with syncope
 During the meal or in the absorptive period after a meal
 With head-rotation, pressure on carotid sinus (as in tumors, shaving, tight collars)
 After exertion
Syncope due to orthostatic hypotension
 After standing-up
 Temporal relationship with start of medication leading to hypotension or changes of dosage
 Prolonged standing especially in crowded, hot places
 Presence of autonomic neuropathy or Parkinsonism
 After exertion
Cardiac syncope
 Presence of deﬁnite structural heart disease
 During exertion or supine
 Preceded by palpitation
 Family history of sudden death
Cerebrovascular syncope
 Arm exercise
 Differences in blood pressure or pulse in the two arms
Note that the causes on the top of the list are more frequent and their likelihood of being the cause
decreases as we move towards the bottom.
Can I Syncope Evaluation
115
tion, the need for hospitalization depends in part on
the immediate risk posed to the patient by the
underlying problem, and in addition on the treatment
proposed. Thus, for example, patients with syncope
accompanying complete heart block, ventricular
tachycardia, acute aortic dissection, or pulmonary
embolism, should be admitted to the hospital and
preferably to an ECG monitored unit. Similarly,
if the initiation of antiarrhythmic drug therapy is
contemplated, the proarrhythmia risk and potential
for ameliorating that risk by in-hospital monitoring
must be considered. On the other hand, most
vasovagal fainters can be sent home after careful
discussion of the nature of the problem and simple
preventative maneuvers (e.g., hydration, avoidance
of hot crowded environments, etc). Later clinic
follow-up suﬃces in most of these cases.
For patients with syncope in whom the etiology
remains ‘suspected’ or entirely ‘unknown’ after the
initial evaluation, the need for hospitalization is
currently less well deﬁned; consequently, there has
been interest in developing so-called ‘‘risk stratiﬁ-
cation’’ methods. The goal of such ‘risk stratiﬁca-
tion’ is to ascertain the relative risk for early adverse
outcomes (particularly mortality, but also falls/
injury risk) using patients’ clinical features and
presenting characteristics. Based on this assessment
the physician determines if hospitalization is pru-
dent. Table 4 summarizes ED risk stratiﬁcation
criteria used in several recent clinical studies or
reports: 1) Syncope Evaluation in the Emergency
Department Study (SEEDS), 2) The San Francisco
Syncope Rule (SFSR) study, 3) the European Society
of Cardiology and American College of Emergency
Physicians (ACEP) guidelines, and 4) The Evalua-
tion of Guidelines in Syncope Study (EGSYS).1,2,9,10)
In each case, stratiﬁcation uses clinical data that is
readily accessible to the ED physician or general
practitioner. These data include patient’s symptoms,
signs, basic laboratory results and clinical experience
(‘judgement’). The latter is, of course, a commodity
that is almost impossible to assess.
The following provides an overview of common
circumstances for which hospitalization is recom-
mended or conversely is usually not needed.
Patients with ‘high risk’
Several prognostic markers identify syncope pa-
tients who should be considered for in-hospital
evaluation. Syncope associated with symptoms
suggestive of acute myocardial ischemia, acute
aortic dissection, signs of congestive heart failure,
and/or suspicion of hemodynamically concerning
underlying structural heart disease (e.g., valvular
aortic or mitral stenosis, severe pulmonary hyper-
tension) have the highest immediate mortality and
recurrence risk. At similar high risk are syncope
patients with certain ECG abnormalities, including
high-grade atrioventricular (AV) block, cardiac
rhythm pauses of 3 to 5 seconds or greater, pre-
excitation syndromes (e.g Wolﬀ-Parkinson White
Syndrome), suspected arrhythmogenic right ventric-
ular cardiomyopathy (ARVD) based on ECG or
imaging evidence (although this is not generally
available in the ED or clinic), idiopathic ventricular
tachycardia, long or short QT syndromes (LQTS,
Short QTS) or Brugada syndrome. Patients with
syncope during exercise, and syncope causing motor
vehicle accidents or severe injury should also be
carefully considered for in-hospital evaluation unless
the history strongly supports the diagnosis of
exercise variant of neurally-mediated reﬂex syncope.
An additional troublesome risk marker in the
syncope patient is a family history of premature
sudden death. This history might be indicative of
ischemic heart disease, but may also signal any of a
variety of familial conditions that may ﬁrst present
as syncope (e.g LQTS, ARVD, Brugada syndrome
etc). In the SEEDS study, a family history of
unexpected death was considered to pose an inter-
mediate risk to the patient with syncope, and
consequently such patients were ﬁrst observed in
an ED-based syncope management unit instead of
immediate hospital admission.9) However, ESC
guidelines strongly recommend hospital admission
for the patients with family history of sudden death.1)
In the Osservatorio Epidemiologico sula Sincope
nel Lazio (OESIL) study, 4 syncope patient charac-
teristics were associated with adverse outcome:
age >65 years, a clinical history of cardiovascular
disease, syncope without prodromal symptoms, and
an abnormal ECG.11) The presence of each charac-
teristic scored one point. One year mortality has been
shown to increase with increasing score (0% for a
score of 0; 0.8% for 1 point; 19.6% for 2 points;
34.7% for 3 points; 57.1% for 4 points; p < 0:0001
for trend).
In the San Francisco Syncope Rule (SFSR) study,
a high-risk was deﬁned as those syncope patients
having any of the following 5 risk factors: abnormal
ECG (non-sinus rhythm or new abnormality), ane-
mia (hematocrit <30%), a complaint of shortness
of breath, systolic hypotension (<90mmHg) and a
history of congestive heart failure.2) The SFSR
criteria was found to be 96% sensitive and 62%
speciﬁc for short-term serious outcomes (7 days
of their initial visit) (Table 4). However, a recent
prospective study to validate the SFSR found a much
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Table 4 Risk Stratiﬁcation Criteria From Several Studies
SEEDS9Þ ESC1Þ ACEP10Þ SFSR2Þ EGSYS score15Þ
Hospital admission strongly Admission
High risk recommended for diagnosis recommended High risk Variable Score
 Chest pain compatible with  Suspected or known  Older age and  History of CHF Palpitations 4
acute coronary syndrome signiﬁcant heart disease associated  Shortness of preceding
 Signs of severe CHF  ECG abnormalities comorbidities breath syncope
 Moderate to severe valvular suggestive of arrhyhmic  Abnormal ECG  Anemia
heart disease syncope (including acute (hct <30%) Heart disease 3
 History of ventricular  Syncope during exercise ischemia,  Sytolic and/or abnormal
arrhythmia  Syncope causing severe dysrhythmias, or hypotension ECG
 ECG/cardiac monitor signs injury signiﬁcant (<90mmHg)
of ischemia  Family history of sudden conduction  Abnormal ECG Syncope 3
 Prolonged QTc (>500ms) death abnormalities) (non-sinus during effort
 Trifascicular block or pauses  Hematocrit <30% rhythm or new
between 2 and 3 s Hospital admission strongly (if obtained) abnormality Syncope 2
 Third degree AV block recommended for treatment  History of while supine
 Persistent sinus bradycardia  Cardiac arrhythmias presence of heart
between 40–60bpm  Syncope due to cardiac failure, coronary Precipitating 1
 Atrial ﬁbrillation or ischemia artery disease, or and/or predisposing
nonsustained ventricular  Syncope secondary to structural heart factors
tachycardia without structural cardiac or disease
symptoms cardiopulmonary diseases Autonomic 1
 Pacemaker or deﬁbrillator  Cardioinhibitory neurally prodromes §
with dysfunction mediated syncope when a
pacemaker implantation
is planned
Intermediate risk Occasionally may need to be
admitted  warm, crowded place/
 Age >50 years  Patients without heart prolonged orthostatis/
 Previous history of CAD, disease but sudden onset fear, pain
MI, HF of palpitations shortly
 CMP without active signs or before syncope § Nausea/vomitting
symptoms on cardiac  Syncope in supine
medications position
 Bundle branch block or Q  Frequent recurrent
wave without acute changes episodes
on ECG  Patients with minimal or
 Family history of premature mild heart disease when
unexplained sudden death there is a high suspicion
(<50 years) for cardiac syncope
 Symptoms not consistent
with reﬂex-mediated or
vasovagal cause
 Cardiac devices without
evidence of dysfunction
 Physician judgement: A
cardiac syncope is possible
Low risk
 Age <50 years




 Symptoms consistent with
reﬂex-mediated or vasovagal
syncope
 Normal ECG ﬁndings
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lower sensitivity (74%) and negative likelihood
ratio (0.5) of the SFSR score to predict serious
outcomes within 7 days of ED visit (death, myocar-
dial infarction, pulmonay embolism, stroke, subar-
achnoid hemorrhage, signiﬁcant hemorrhage, any
condition causing or likely to cause a return ED visit
and hospitalization for a related event).12)
A recent study, Short Term Prognosis of Syncope
(STePS), evaluated the risk factors for both short-
term and long-term severe outcomes in a group of
676 patients presenting with syncope. Severe out-
comes included death, the need for major therapeutic
procedures (cardiopulmonary resuscitation, pace-
maker or deﬁbrillator implant, and intensive care
unit admittance, and acute antiarrhythmic therapy),
and early (within 10 days) readmission to hospital.
An abnormal electrocardiogram, concomitant trau-
ma, absence of symptoms of impending syncope,
and male gender were associated with a higher risk
of severe outcome by 10 days. However, the positive
predictive value was low (11%–14%) due to rela-
tively low rate of these events. The long term
(1 year) severe outcomes correlated with age >65
years, history of neoplasms, cerebrovascular dis-
eases, structural heart diseases, and ventricular
arrhythmias13).
Patients with intermediate risk
Syncope associated with age >50 years, history of
structural heart disease but without signs of active
consequences of disease, certain ECG abnormalities,
family history of sudden death, cardiac devices
without evidence of dysfunction, symptoms not
consistent with vasovagal or reﬂex-mediated syncope
and physician’s judgement that a cardiac syncope is
possible constitute the patient group with intermedi-
ate risk for adverse outcome (Table 4, SEEDS study).
In SEEDS, patients with intermediate risk were
placed in an ED-based syncope management unit
where they received continuous cardiac monitoring
for up to 6 hours, hourly vital signs, orthostatic blood
pressure checks, and echocardiogram for patients
with abnormal cardiovascular examination or ECG
ﬁndings. During this evaluation, if patients developed
high risk features they were admitted to the hospital,
otherwise they were discharged to be followed-up in
an outpatient clinic in <72 hours. For ED’s without
a well-developed syncope management unit, an
observation unit similar to that often used for ‘chest
pain’ assessment may prove useful, although careful
additional staﬀ training would be needed.
Patients with low risk
Patients in this group typically have no evidence
of structural heart disease and have a normal
baseline ECG. The syncope is considered of a
‘relatively benign’ nature; that is, the syncope is
thought to be of neurally-mediated reﬂex or ortho-
static cause. In this setting the risk of a life-
threatening cardiac syncope is low, but ‘falls risk’
(and potential for physical injury) is still a consid-
eration especially in older individuals. These patients
can generally be stabilized in the ED or clinic. They
can be reassured that they have a good prognosis in
terms of survival, but must be warned regarding
injury and accident risk. Consequently, before being
sent home they should be provided cautionary advice
regarding hydration, avoidance of provocative fac-
tors, driving concerns, avocation risk, and occupa-
tion risk given the real risk of recurrent events.
Further, prompt follow-up in a ‘syncope’ or ‘falls’
clinic should be arranged so that deﬁnitive therapy is
instituted in a timely manner.
Syncope management units
An as yet incompletely answered question is
whether ‘‘syncope management units’’ (SMU) can
help solve the problem of too many low- and
intermediate-risk syncope patients being admitted to
hospital where they often are submitted to unneeded
expensive diagnostic tests. In this regard, two recent
prospective observational studies demonstrated im-
proved syncope management by use of a team of
specially-trained personnel in a SMU.
The SEEDS study examined the utility of a SMU
in the ED for patients with syncope who are
considered at intermediate risk for adverse cardio-
vascular outcome.9) In this prospective, single-
center, unblinded randomized study, 103 patients
were randomized to ‘standard care’ or SMU care
after initial assessment with a complete history,
physical examination and ECG. The study found that
in the ED, a presumptive diagnosis of the cause of
syncope was signiﬁcantly increased from 10% in the
‘standard care’ patients to 67% among those who
underwent SMU evaluation; hospital admission was
reduced from 98% among the ‘standard care’
patients to 43% among the SMU patients; the total
length of patient-hospital days was reduced by
>50% for patients in the SMU group.
The potential for the ESC Guidelines to facilitate
management of syncope patients referred to ED’s of
11 Italian general hospitals was investigated in the
The Evaluation of Guidelines in Syncope Study
(EGSYS-2).14) The application of guidelines to
clinical circumstances was facilitated by use of
purpose-designed software in addition to personnel
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training at test sites. A deﬁnite diagnosis was
established in 98% of cases, with the vast majority
being either neurally-mediated or orthostatic faints.
The initial evaluation (history, physical examination,
and electrocardiogram) established a diagnosis in
50% of cases. The investigators further compared
the outcomes of 745 patients managed with this
aforementioned ‘‘standardized care’’ system to 929
patients managed with usual care. In the group
designated to ‘‘standardized-care’’, hospitalizations
were fewer, in-hospital stay was shorter, fewer tests
were performed per patient, and cost per patient and
mean cost per diagnosis were lower. An EGSYS
score was derived from this study to predict cardiac
syncope at initial ED evaluation. An abnormal ECG
and/or heart disease, palpitations before syncope,
syncope during eﬀort or in supine position, absence
of autonomic prodromes, and absence of predispos-
ing and/or precipitating factors were found to be
predictors of cardiac syncope. A score from +4 to
1 was assigned, and a score 3 identiﬁed cardiac
syncope with 95% sensitivity and 67% speciﬁcity15)
(Table 4).
Conclusion
Syncope is a very common clinical problem that is
often ﬁrst evaluated by busy ED physicians and
general practitioners. Delineating the underlying
etiology and the risk of adverse outcome is often
challenging. In the majority of the patients present-
ing with syncope a careful history, physical exami-
nation including orthostatic blood pressure measure-
ments and ECG can often establish the diagnosis
with substantial certainty. In other instances, when
the initial evaluation is inconclusive, further evalua-
tion is needed. In this setting, the studies should be
carefully selected, and a ‘shotgun’ approach studi-
ously avoided. The mere presence of an abnormal
ﬁnding should not lead one to assume that the
‘cause’ has been found. In any event, whether the
diagnosis is quickly established or not, the need for
in-hospital care inevitably arises. In this regard,
several potentially useful risk stratiﬁcation criteria
have been advocated with the goal of better guiding
the decision-making process regarding immediate
need for patient admission to hospital or safety of
discharge from the ED with later clinic assessment.
While none of these systems are perfect, they do
oﬀer reasonable strategies for identifying high-risk,
intermediate-risk, and low-risk patients. High-risk
patients need to be admitted to the hospital for
further diagnosis and treatment. Intermediate-risk
patients may warrent brief observation in ED-based
SMU, but absent evolution of any ‘high-risk’
features, are best evalauted on an outpatient basis
in syncope or falls clinic. More widespread develop-
ment of such SMUs and syncope/falls clinics is
strongly encouraged; together, they have been
shown to reduce both hospital costs and number
of undiagnosed cases. Finally, low-risk patients can
be safely discharged from the ED with counsel-
ling, and later follow-up in an ambulatory care
setting.
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Appendix: Medical History in Syncope Patients
Attention to each of the following key diagnostic
components may prove helpful as part of the medical
history taking in order to assure that a reported T-
LOC event is true syncope. Thus, a careful history
should focus on circumstances immediately before
the attack, its onset, the attack, the end of the attack,
and the patient’s background.
Questions about the circumstances just prior
to the attack
i. Position:
Prone or supine: Cardiac arrhythmia (tachy- or
brady-arrhythmia)
Standing: Vasovagal syncope, Orthostatic hy-
potension




Rest: Cardiac or cardiopulmonary causes (see
Table 2)
Urination, defecation, cough, swallowing: Sit-
uational syncope (neurally-mediated syncope)
iii. Predisposing factors
Prolonged standing, hot or crowded places:
Vasovagal syncope, orthostatic hypotension
Fear, intense pain, unpleasant sight or smell:
Vasovagal syncope
Neck movements: Carotid sinus syndrome
New medication: Temporal relationship with
start of medication leading to orthostatic
hypotension
Questions about the onset of attack (e.g
warning symptoms)
i. Nausea, vomiting, abdominal discomfort, feel-
ing of cold or hot, sweating, blurred vision:
Neurally-mediated syncope (e.g Vasovagal
syncope)
ii. Aura: Seizure
Questions about the attack (eyewitnesses)
i. Way of falling: Loss of voluntary muscle
control is an inherent part of loss of conscious-
ness. Consequently, if standing, the fainter falls
down; if seated he or she slumps over.
ii. Rapid onset: Generally, onset of syncope is
rapid, being no more than 10 to 20 sec after
onset of warning symptoms. However, many
fainters either do not experience or are unaware
of any premonitory symptoms. This lack of
warning is particularly prevalent in older
individuals.
iii. Jerky movements: In syncope, it is not un-
common for patients to exhibit jerky move-
ments of the arms and legs for a brief period
of time; non-expert bystanders may incorrect-
ly interpret these movements as a ‘‘seizure’’ or
a ‘‘ﬁt’’. However, the jerky movements during
a faint diﬀer from those accompanying a
grand mal epileptic seizure in several ways.
They are of shorter duration, they tend to
occur after the loss of consciousness has set in
rather than before, and they do not have the
‘‘tonic–clonic’’ features of a true grand mal
seizure.
iv. Tongue biting: Tongue biting, particularly if
it is lateral has a high speciﬁcity for seizure
disorder. Because of low sensitivity, absence of
tongue bites has no diagnostic signiﬁcance.16)
Midline tongue biting is usually seen in seizure




Cyanosis: Cardiac or cardiopulmonary causes
Questions about the end of the attack
i. A spontaneous, complete and prompt recovery
from the faint excludes a number of conditions
which may cause T-LOC (e.g coma, intoxicat-
ed states, stroke etc). On the other hand, in
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certain forms of syncope, particularly the
vasovagal faint, recovery may be marked by
fatigue with the need for sleep, and a general
sense of diminished energy for some lengthy
period of time (often hours in duration).
ii. Confusion: After an episode of syncope, pa-
tients may brieﬂy appear disoriented or con-
fused, but this resolves within moments and is
often shorter than the post-ictal period associ-
ated with general seizures.
iii. Urinary or fecal incontinence: Seizure
Questions about the background
i. Past medical history: Previous cardiac disease,
neurological history, metabolic disorders (e.g
diabetes, etc)
ii. Medications: Many drugs prolong the QT
interval and are associated with life-threatening
dysrhythmias. Vasoactive drugs such as anti-
hypertensives, vasodilators used for angina,
and those used for erectile dysfunction can
cause syncope. Drug related syncope is espe-
cially common in elderly patients taking multi-
ple medications.17)
iii. Family history: A family history of premature
sudden death should alert the physician to the
possibility of serious congenital conduction
abnormalities such as long-QT syndrome, pre-
excitation syndromes, Brugada syndrome, etc
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